42 related articles for article (PubMed ID: 27055065)
1. Hijacking monopolar spindle 1 (MPS1) for various cancer types by small molecular inhibitors: Deep insights from a decade of research and patents.
Liang C; Zhou Y; Xin L; Kang K; Tian L; Zhang D; Li H; Zhao Q; Gao H; Shi Z
Eur J Med Chem; 2024 Jul; 273():116504. PubMed ID: 38795520
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function.
Kwiatkowski N; Jelluma N; Filippakopoulos P; Soundararajan M; Manak MS; Kwon M; Choi HG; Sim T; Deveraux QL; Rottmann S; Pellman D; Shah JV; Kops GJ; Knapp S; Gray NS
Nat Chem Biol; 2010 May; 6(5):359-68. PubMed ID: 20383151
[TBL] [Abstract][Full Text] [Related]
3. Development of MPS1 Inhibitors: Recent Advances and Perspectives.
Zeng Y; Ren X; Jin P; Zhang Y; Zhuo M; Wang J
J Med Chem; 2023 Dec; 66(24):16484-16514. PubMed ID: 38095579
[TBL] [Abstract][Full Text] [Related]
4. Scaffold-focused virtual screening: prospective application to the discovery of TTK inhibitors.
Langdon SR; Westwood IM; van Montfort RL; Brown N; Blagg J
J Chem Inf Model; 2013 May; 53(5):1100-12. PubMed ID: 23672464
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma.
Simon Serrano S; Sime W; Abassi Y; Daams R; Massoumi R; Jemaà M
Sci Rep; 2020 Jul; 10(1):11997. PubMed ID: 32686724
[TBL] [Abstract][Full Text] [Related]
6. High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.
Miduturu CV; Deng X; Kwiatkowski N; Yang W; Brault L; Filippakopoulos P; Chung E; Yang Q; Schwaller J; Knapp S; King RW; Lee JD; Herrgard S; Zarrinkar P; Gray NS
Chem Biol; 2011 Jul; 18(7):868-79. PubMed ID: 21802008
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor.
Sun Y; Chen Z; Liu G; Chen X; Shi Z; Feng H; Yu L; Li G; Ding K; Huang H; Zhang Z; Xu S
Bioorg Chem; 2024 Feb; 143():107053. PubMed ID: 38159497
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Pyrido[3,4-
Van Hoof M; Claes S; Boon K; Van Loy T; Schols D; Dehaen W; De Jonghe S
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903345
[TBL] [Abstract][Full Text] [Related]
9. TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
Qi G; Ma H; Li Y; Peng J; Chen J; Kong B
Cell Death Dis; 2021 Dec; 12(12):1135. PubMed ID: 34876569
[TBL] [Abstract][Full Text] [Related]
10. Studies of Interaction Mechanism between Pyrido [3,4-
Xing C; Zhou X; Chen C; Sun W; Zheng Q; Liang D
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443663
[TBL] [Abstract][Full Text] [Related]
11. Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4- d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N
Woodward HL; Innocenti P; Cheung KJ; Hayes A; Roberts J; Henley AT; Faisal A; Mak GW; Box G; Westwood IM; Cronin N; Carter M; Valenti M; De Haven Brandon A; O'Fee L; Saville H; Schmitt J; Burke R; Broccatelli F; van Montfort RLM; Raynaud FI; Eccles SA; Linardopoulos S; Blagg J; Hoelder S
J Med Chem; 2018 Sep; 61(18):8226-8240. PubMed ID: 30199249
[TBL] [Abstract][Full Text] [Related]
12. Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.
Chen Y; Yu W; Jiang CC; Zheng JG
Molecules; 2018 Jun; 23(6):. PubMed ID: 29925769
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition.
Fearon D; Westwood IM; van Montfort RLM; Bayliss R; Jones K; Bavetsias V
Bioorg Med Chem; 2018 Jul; 26(11):3021-3029. PubMed ID: 29764757
[TBL] [Abstract][Full Text] [Related]
14. Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division.
Maia ARR; Linder S; Song JY; Vaarting C; Boon U; Pritchard CEJ; Velds A; Huijbers IJ; van Tellingen O; Jonkers J; Medema RH
Br J Cancer; 2018 Jun; 118(12):1586-1595. PubMed ID: 29736010
[TBL] [Abstract][Full Text] [Related]
15. Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.
Hiruma Y; Koch A; Hazraty N; Tsakou F; Medema RH; Joosten RP; Perrakis A
J Biol Chem; 2017 Sep; 292(35):14496-14504. PubMed ID: 28726638
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy.
Faisal A; Mak GWY; Gurden MD; Xavier CPR; Anderhub SJ; Innocenti P; Westwood IM; Naud S; Hayes A; Box G; Valenti MR; De Haven Brandon AK; O'Fee L; Schmitt J; Woodward HL; Burke R; vanMontfort RLM; Blagg J; Raynaud FI; Eccles SA; Hoelder S; Linardopoulos S
Br J Cancer; 2017 Apr; 116(9):1166-1176. PubMed ID: 28334731
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.
Mason JM; Wei X; Fletcher GC; Kiarash R; Brokx R; Hodgson R; Beletskaya I; Bray MR; Mak TW
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3127-3132. PubMed ID: 28270606
[TBL] [Abstract][Full Text] [Related]
18. Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach.
Innocenti P; Woodward HL; Solanki S; Naud S; Westwood IM; Cronin N; Hayes A; Roberts J; Henley AT; Baker R; Faisal A; Mak GW; Box G; Valenti M; De Haven Brandon A; O'Fee L; Saville H; Schmitt J; Matijssen B; Burke R; van Montfort RL; Raynaud FI; Eccles SA; Linardopoulos S; Blagg J; Hoelder S
J Med Chem; 2016 Apr; 59(8):3671-88. PubMed ID: 27055065
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
